Colorectal Neoplasms  >>  Pexa-Vec (pexastimogene devacirepvec)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
NCT01329809: Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Terminated
2a
2
Canada
Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594), JX-594
Jennerex Biotherapeutics
Colorectal Carcinoma
01/12
03/13

Download Options